Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Signal Transduction
53%
Kinome
45%
Vascular Endothelial Growth Factor
43%
Epidermal Growth Factor Receptor
40%
Kinase
39%
Phosphotransferase
39%
Tumor Progression
38%
Peptide Microarray
38%
DNA Damage Response
35%
Vascular Endothelial Growth Factor A
33%
Receptor Tyrosine Kinase
31%
Promoter Region
27%
DNA Damage
25%
Cell Survival
25%
Tyrosine Kinase
25%
Messenger RNA
23%
Cell Proliferation
22%
P53
22%
Signaling Protein
22%
Droplet Digital Polymerase Chain Reaction
20%
Tyrosine Kinase Inhibitor
16%
Transforming Growth Factor Beta
16%
IKZF1
16%
Methylation
16%
Precursor
16%
Activating Transcription Factor 2
16%
Ephrin
16%
B Cell
16%
Philadelphia Chromosome
16%
Transcription Factor RUNX1
16%
DNA Repair
16%
P21
16%
CREB
16%
Vascular Endothelial Growth Factor C
16%
Drug Exposure
16%
STAT Protein
16%
RUNX1
16%
Cell Adhesion
16%
Drug Resistance
16%
Cell Invasion
16%
Reprogramming
16%
Phospholipase C
16%
Fusion Gene
16%
Mitogen-Activated Protein Kinase
16%
Cell Death
15%
Downregulation
15%
VEGF Receptors
13%
Angiogenesis
12%
Mouse
11%
Medicine and Dentistry
Acute Myeloid Leukemia
66%
Leukemia
34%
Lung Cancer
33%
Neoplasm
32%
Leukemia Cell
30%
Vasculotropin
22%
Epidermal Growth Factor Receptor
19%
Tumor Progression
19%
Phosphotransferase
19%
Resistance Mutation
19%
Pediatrics
18%
Protein Tyrosine Kinase
17%
Activating Transcription Factor 2
16%
Recurrence Free Survival
16%
Secretion (Process)
16%
Vasculotropin C
16%
Non-Hodgkin Lymphoma
16%
SCID Mouse
16%
Tumor Vascularization
16%
Formaldehyde
16%
Tyrosine-Kinase Inhibitor
16%
Pediatric Acute Myeloid Leukemia
16%
Hematopoietic Stem Cell
16%
Diabetes Mellitus
16%
Pilocytic Astrocytoma
16%
Glioblastoma
16%
Pediatric Brain Tumor
16%
Prognostic Factor
16%
Acute Lymphoblastic Leukemia
16%
Antibody Therapy
16%
Fusion Gene
16%
ALK Inhibitor
16%
Cell Survival
15%
Vasculotropin Receptor 2
15%
In Vitro
13%
Angiopoietin 2
12%
Non Small Cell Lung Cancer
12%
Mitogen-Activated Protein Kinase
10%
Biopsy Technique
10%
Leukocyte
9%
Droplet Digital Polymerase Chain Reaction
9%
Blast Cell
7%
Hematopoietic Stem Cell
7%
Hemangioblast
7%
Cyclic AMP Responsive Element Binding Protein
6%
Malignant Neoplasm
6%
Tumor Cell
6%
Reverse Transcription Polymerase Chain Reaction
6%
Signal Transduction
5%
Progression Free Survival
5%
Keyphrases
Epidermal Growth Factor Receptor
33%
Acute Lymphoblastic Leukemia
33%
Target Discovery
33%
Pediatric Medulloblastoma
16%
Binding Protein
16%
Signaling Profile
16%
Responsive Element
16%
Pediatric Low-grade Astrocytoma
16%
Tumor Angiogenic
16%
Drug Responsiveness
16%
Non-obese Diabetic
16%
Metagenomic Next-generation Sequencing (mNGS)
16%
Pediatric Acute Lymphoblastic Leukemia
16%
EphB1
16%
Phospholipase Cγ1
16%
Amplicon-based
16%
Severe Combined Immunodeficient Mice
16%
Cyclic Adenosine Monophosphate (cAMP)
16%
Clinical Value
16%
Growth Factor Secretion
16%
Signal Transduction Pathway
16%
Acute Myeloid Leukemia
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Kinase Activity Profiling
16%
Copy number Gain
16%
Tumor-stroma Interaction
16%
Paediatric B-cell Precursor Acute Lymphoblastic Leukaemia
16%
Philadelphia Chromosome-negative
16%
Second-generation Tyrosine Kinase Inhibitors
16%
Ephrin-B1
11%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
10%
AML1
9%
Hemangioblast
8%
Angiopoietin-2
8%
Leukemia Patients
6%
Phosphorylation
6%
EphB4
5%
Eph-ephrin Signaling
5%
Canertinib
5%
Endothelial Lineage
5%
Autologous Peripheral Blood Stem Cells
5%
Shh Signaling Pathway
5%
